Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

258 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The effect of lipid-lowering treatment on indices of MASLD in familial hypercholesterolemia patients.
Boutari C, Rizos CV, Liamis G, Skoumas I, Rallidis L, Garoufi A, Kolovou G, Sfikas G, Tziomalos K, Skalidis E, Kotsis V, Doumas M, Stamatelopoulos K, Lambadiari V, Anagnostis P, Boufidou A, Giannakopoulou V, Anastasiou G, Petkou E, Vlachopoulos C, Dima I, Fakas G, Papathanasiou KA, Attilakos A, Kolovou V, Koumaras C, Agapakis D, Zacharis E, Antza C, Milionis H, Liberopoulos E, Mantzoros CS. Boutari C, et al. Among authors: anagnostis p. Clin Nutr. 2024 Oct 16;43(12):84-91. doi: 10.1016/j.clnu.2024.10.020. Online ahead of print. Clin Nutr. 2024. PMID: 39437569
Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study.
European Atherosclerosis Society Familial Hypercholesterolaemia Studies Collaboration (EAS FHSC). European Atherosclerosis Society Familial Hypercholesterolaemia Studies Collaboration (EAS FHSC). Lancet Diabetes Endocrinol. 2024 Nov;12(11):811-823. doi: 10.1016/S2213-8587(24)00221-3. Epub 2024 Oct 4. Lancet Diabetes Endocrinol. 2024. PMID: 39374602 Free article.
Recommended measurement instruments for menopausal vasomotor symptoms: the COMMA (Core Outcomes in Menopause) consortium.
Lensen S, Paramanandam VS, Gabes M, Kann G, Donhauser T, Waters NF, Li AD, Peate M, Susanto NS, Caughey LE, Rangoonwal F, Liu J, Condron P, Anagnostis P, Archer DF, Avis NE, Bell RJ, Carpenter JS, Chedraui P, Christmas M, Davies M, Hillard T, Hunter MS, Iliodromiti S, Jaff NG, Jaisamrarn U, Joffe H, Khandelwal S, Kiesel L, Maki PM, Mishra GD, Nappi RE, Panay N, Pines A, Roberts H, Rozenberg S, Rueda C, Shifren J, Simon JA, Simpson P, Siregar MFG, Stute P, Garcia JT, Vincent AJ, Wolfman W, Hickey M. Lensen S, et al. Among authors: anagnostis p. Menopause. 2024 Jul 1;31(7):582-590. doi: 10.1097/GME.0000000000002370. Epub 2024 Apr 30. Menopause. 2024. PMID: 38688464
The association of vasomotor symptoms with fracture risk and bone mineral density in postmenopausal women: a systematic review and meta-analysis of observational studies.
Anagnostis P, Lallas K, Pappa A, Avgeris G, Beta K, Damakis D, Fountoukidou E, Zidrou M, Lambrinoudaki I, Goulis DG. Anagnostis P, et al. Osteoporos Int. 2024 Aug;35(8):1329-1336. doi: 10.1007/s00198-024-07075-8. Epub 2024 Apr 2. Osteoporos Int. 2024. PMID: 38563960 Free PMC article. Review.
Physical signs and atherosclerotic cardiovascular disease in familial hypercholesterolemia: the HELLAS-FH Registry.
Rallidis LS, Rizos CV, Papathanasiou KA, Liamis G, Skoumas I, Garoufi A, Kolovou G, Tziomalos K, Skalidis E, Kotsis V, Sfikas G, Doumas M, Anagnostis P, Lambadiari V, Giannakopoulou V, Kiouri E, Anastasiou G, Petkou E, Koutagiar I, Attilakos A, Kolovou V, Zacharis E, Antza C, Koumaras C, Boutari C, Liberopoulos E. Rallidis LS, et al. Among authors: anagnostis p. J Cardiovasc Med (Hagerstown). 2024 May 1;25(5):370-378. doi: 10.2459/JCM.0000000000001612. Epub 2024 Mar 19. J Cardiovasc Med (Hagerstown). 2024. PMID: 38526957
Obesity and atherosclerotic cardiovascular disease in adults with heterozygous familial hypercholesterolemia: An analysis from HELLAS-FH registry.
Barkas F, Rizos CV, Liamis G, Skoumas I, Garoufi A, Rallidis L, Kolovou G, Tziomalos K, Skalidis E, Sfikas G, Kotsis V, Doumas M, Anagnostis P, Lambadiari V, Anastasiou G, Koutagiar I, Attilakos A, Kiouri E, Kolovou V, Polychronopoulos G, Koutsogianni AD, Zacharis E, Koumaras C, Antza C, Boutari C, Liberopoulos E. Barkas F, et al. Among authors: anagnostis p. J Clin Lipidol. 2024 May-Jun;18(3):e394-e402. doi: 10.1016/j.jacl.2024.01.005. Epub 2024 Jan 24. J Clin Lipidol. 2024. PMID: 38331687
Hyperparathyroidism and Peripheral Arterial Disease.
Antignani PL, Jezovnik MK, Blinc A, Mikhailidis DP, Anagnostis P, Schernthaner GH, Jensterle M, Studen KB, Sabovic M, Poredos P. Antignani PL, et al. Among authors: anagnostis p. Curr Vasc Pharmacol. 2024;22(2):88-94. doi: 10.2174/0115701611280905231227045826. Curr Vasc Pharmacol. 2024. PMID: 38284694 Review.
Familial Hypercholesterolemia in the Elderly: An Analysis of Clinical Profile and Atherosclerotic Cardiovascular Disease Burden from the Hellas-FH Registry.
Antza C, Rizos CV, Kotsis V, Liamis G, Skoumas I, Rallidis L, Garoufi A, Kolovou G, Tziomalos K, Skalidis E, Sfikas G, Doumas M, Lambadiari V, Anagnostis P, Stamatelopoulos K, Anastasiou G, Koutagiar I, Kiouri E, Kolovou V, Polychronopoulos G, Zacharis E, Koumaras C, Boutari C, Milionis H, Liberopoulos E. Antza C, et al. Among authors: anagnostis p. Biomedicines. 2024 Jan 19;12(1):231. doi: 10.3390/biomedicines12010231. Biomedicines. 2024. PMID: 38275402 Free PMC article.
258 results